Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine for adolescent female MDD non-responders
NCT00851006Phase 2Completed
- Sponsor
- University of Utah
- Start
- Apr 2009
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of creatine in major depressive disorder (MDD), sponsored by University of Utah. Started Apr 2009; status: completed.
02
Drugs
creatine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00851006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00851006.